Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting

Kim, Christina; Kerr, Thomas; Li, Kathy; Zhang, Ruth; Tyndall, Mark W.; Montaner, Julio S. G.; Wood, Evan
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p270
Academic Journal
Background: There has emerged growing recognition of the link between housing and health. Since Vancouver, Canada has had increasing concerns with homelessness brought about by urban renewal in the lead-up to the 2010 Winter Olympic Games, we evaluated hepatitis C virus (HCV) incidence among injection drug users (IDU) with and without stable housing. Methods: Data were derived from a collaboration between two prospective cohort studies of IDU in Vancouver, Canada. Using Cox Proportional Hazards regression, we compared HCV incidence among participants with and without stable housing, and determined independent predictors of HCV incidence. Results: Overall, 3074 individuals were recruited between May 1996 and July 2007, among whom 2541 (82.7%) were baseline HCV-infected. Among the 533 (17.3%) individuals who were not HCV-infected at baseline, 147 tested HCV antibody-positive during follow-up, for an incidence density of 16.89 (95% confidence interval: 14.76 - 19.32) per 100 person-years. In a multivariate Cox regression model, unstable housing remained independently associated with HCV infection (relative hazard = 1.47 (1.02 - 2.13). Conclusion: HCV prevalence and incidence are high in this setting and were associated with unstable housing. Efforts to protect existing low-income housing and improve access to housing may help to reduce HCV incidence.


Related Articles

  • Low rates of hepatitis C testing among people who inject drugs in Thailand: implications for peer-based interventions. Ti, L.; Kaplan, K.; Hayashi, K.; Suwannawong, P.; Wood, E.; Kerr, T. // Journal of Public Health;Dec2013, Vol. 35 Issue 4, p578 

    Background Regular testing for hepatitis C virus (HCV) provides an opportunity for HCV prevention and treatment efforts. In Thailand, the barriers and facilitators of HCV testing among people who inject drugs (IDU) are not known. Methods Using data derived from the Mitsampan Community Research...

  • Hepatitis C Virus Infection among Prisoners in the California State Correctional System. Fox, Rena K.; Currie, Sue L.; Evans, Jennifer; Wright, Teresa L.; Tobler, Leslie; Phelps, Bruce; Busch, Michael P.; Page-Shafer, Kimberly A. // Clinical Infectious Diseases;7/15/2005, Vol. 41 Issue 2, p177 

    Background. Incarcerated populations are at high risk for hepatitis C virus (HCV) infection, yet prisoners are not routinely screened or treated for HCV infection. Understanding the risk factors of HCV infection among prisoners could help improve HCV interventions. Methods. Prevalence and risk...

  • Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men. Turner, J. M.; Rider, A. T.; Imrie, J.; Copas, A. J.; Edwards, S. G.; Dodds, J. P.; Stephenson, J. M. // Sexually Transmitted Infections;Aug2006, Vol. 82 Issue 4, p298 

    Objective: To explore the associations between self reported high risk sexual behaviours and subsequent diagnosis with hepatitis C virus (HCV) infection. Methods: The Sex, Health and Anti-Retrovirals Project (SHARP) was a cross sectional study of sexual behaviour in HIV positive, men who have...

  • Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C. Sartori, Massimo; Andorno, Silvano; Pagliarulo, Michela; Rigamonti, Cristina; Bozzola, Cristina; Pergolini, Patrizia; Rolla, Roberta; Suno, Anna; Boldorini, Renzo; Bellomo, Giorgio; Albano, Emanuele // Gut;May2007, Vol. 56 Issue 5, p693 

    Background: Iron accumulation is a well-known risk factor far the progression of chronic hepatitis C (CHC) to fibrosis. However, the profibrogenic role of the genes controlling iron homeostasis is still controversial. Aim: To evaluate the relative role of haemachromatosis (HFE), ferroportin and...

  • The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. Chen-Hua Liu; Cheng-Chao Liang; Chun-Jen Liu; Shih-Jer Hsu; Jou-Wei Lin; Shih-I. Chen; Peir-Haur Hung; Hung-Bin Tsai; Ming-Yang Lai; Pei-Jer Chen; Jun-Herng Chen; Ding-Shinn Chen; Jia-Horng Kao // Kidney International;Jul2010, Vol. 78 Issue 1, p103 

    Percutaneous liver biopsy is the gold standard for staging hepatic fibrosis of hemodialysis patients with chronic hepatitis C before renal transplantation or antiviral therapy. Concerns exist, however, about serious post-biopsy complications. To evaluate a more simple approach using standard...

  • Comparative Evaluation of Trace Metals in the Blood of Hepatitis C Patients and Healthy Donors. Saghir, Mehwish; Shaheen, Nazia; Shah, Munir // Biological Trace Element Research;Nov2011, Vol. 143 Issue 2, p751 

    Hepatitis C is one of the common types of chronic liver disease, and its plausible association with trace metal imbalance has been investigated in the present study. The blood samples of hepatitis C patients and healthy donors were analysed for trace metals (Ca, Cd, Co, Cr, Cu, Fe, K, Li, Mg,...

  • Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan. Uto, Hirofumi; Kurogi, Joji; Takahama, Yuka; Kusumoto, Kazunori; Hayashi, Katsuhiro; Ido, Akio; Kohara, Michinori; Stuver, Sherri O.; Moriuchi, Akihiro; Hasegawa, Susumu; Oketani, Makoto; Tsubouchi, Hirohito // Journal of Gastroenterology;Aug2007, Vol. 42 Issue 8, p673 

    The clinical features of hepatitis C virus (HCV) carriers with persistently normal alanine aminotransferase (PNALT) levels (ALT ≤ 34 IU/l) have not been fully elucidated. We investigated clinical factors associated with ALT flare-up in PNALT individuals in a HCV hyperendemic area of Japan....

  • Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C. Numata, Makoto; Kagawa, Tatehiro; Kojima, Sei-ichiro; Hirose, Shunji; Nagata, Naruhiko; Shiraishi, Koichi; Watanabe, Norihito; Shiozawa, Hirokazu; Nishizaki, Yasuhiro; Motegi, Shigeyuki; Takashimizu, Shinji; Kamochi, Jun-ichiro; Wasada, Mitsuru; Ohno, Takashi; Tei, Yoshihiro; Nakano, Atsushi; Yamada, Takuji; Atsukawa, Kazuhiro; Watanabe, Tetsu; Mine, Tetsuya // Hepatitis Research & Treatment;2010, p1 

    To clarify the impact of adherence, we treated 122 genotype 1 high viral titer chronic hepatitis C patients with pegylated interferon (peg-IFN) and ribavirin for 48 weeks at nine referral hospitals, and evaluated the prognostic factors with a focus on the adherence to the treatment. This study...

  • Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b. Jiansheng Li; Meng Wang; Zhen Zhang; Dongli Yue; Yi Zhang; Zhiqin Li; Hongyu Zhang; Rong Zhou; Xiaogang Li; Shuhuan Wu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 5, p7446 

    The standard treatment, pegylated interferon (PEG-IFN) plus ribavirin (RBV), for patients with chronic hepatitis C (CHC), does not provide a sustained virologic response (SVR) in a large majority of patients. In the present study, 211 treatment-naïve patients with the hepatitis C virus (HCV)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics